74 related articles for article (PubMed ID: 2243336)
1. Opiate-receptor antagonist improves metabolic recovery and limits neurochemical alterations associated with reperfusion after global brain ischemia in rats.
Faden AI; Shirane R; Chang LH; James TL; Lemke M; Weinstein PR
J Pharmacol Exp Ther; 1990 Nov; 255(2):451-8. PubMed ID: 2243336
[TBL] [Abstract][Full Text] [Related]
2. Effects of hyperglycemia on the time course of changes in energy metabolism and pH during global cerebral ischemia and reperfusion in rats: correlation of 1H and 31P NMR spectroscopy with fatty acid and excitatory amino acid levels.
Widmer H; Abiko H; Faden AI; James TL; Weinstein PR
J Cereb Blood Flow Metab; 1992 May; 12(3):456-68. PubMed ID: 1569139
[TBL] [Abstract][Full Text] [Related]
3. Effect of dichloroacetate on recovery of brain lactate, phosphorus energy metabolites, and glutamate during reperfusion after complete cerebral ischemia in rats.
Chang LH; Shimizu H; Abiko H; Swanson RA; Faden AI; James TL; Weinstein PR
J Cereb Blood Flow Metab; 1992 Nov; 12(6):1030-8. PubMed ID: 1356994
[TBL] [Abstract][Full Text] [Related]
4. Levels of endogenous opioids and effects of an opiate antagonist during regional cerebral ischemia in rats.
Andrews BT; McIntosh TK; Gonzales MF; Weinstein PR; Faden AI
J Pharmacol Exp Ther; 1988 Dec; 247(3):1248-54. PubMed ID: 3204516
[TBL] [Abstract][Full Text] [Related]
5. ATP and pH predictors of histologic damage following global cerebral ischemia in the rat.
Sárváry E; Halsey JH; Conger KA; Garcia JH; Kovách AG
Acta Physiol Hung; 1994; 82(2):109-24. PubMed ID: 7887171
[TBL] [Abstract][Full Text] [Related]
6. Opiate-receptor antagonist nalmefene improves neurological recovery after traumatic spinal cord injury in rats through a central mechanism.
Faden AI; Sacksen I; Noble LJ
J Pharmacol Exp Ther; 1988 May; 245(2):742-8. PubMed ID: 3367315
[TBL] [Abstract][Full Text] [Related]
7. Effects of the new eburnamenine derivative RU 24722 on EEG recovery and cerebral energy metabolism after complete ischemia.
Barzaghi F; Dragonetti M; Formento ML; Boissier JR
Arzneimittelforschung; 1985; 35(2):472-7. PubMed ID: 4039569
[TBL] [Abstract][Full Text] [Related]
8. Dihydropyridine calcium antagonists reduce the consumption of high-energy phosphates in the rat brain. A study using combined 31P/1H magnetic resonance spectroscopy and 31P saturation transfer.
Rudin M; Sauter A
J Pharmacol Exp Ther; 1989 Nov; 251(2):700-6. PubMed ID: 2810119
[TBL] [Abstract][Full Text] [Related]
9. Effect of the calcium entry blocker nimodipine on the metabolism of nucleic acids in rat brain ischemia.
Kostron H; Sperl W; Murr C; Pillwein K
Adv Neurol; 1990; 52():133-9. PubMed ID: 2396509
[TBL] [Abstract][Full Text] [Related]
10. Opiate antagonist nalmefene improves intracellular free Mg2+, bioenergetic state, and neurologic outcome following traumatic brain injury in rats.
Vink R; McIntosh TK; Rhomhanyi R; Faden AI
J Neurosci; 1990 Nov; 10(11):3524-30. PubMed ID: 2230942
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous metabolic changes in the calf muscle of the rat during ischaemia-reperfusion: in vivo analysis by 31P nuclear magnetic resonance chemical shift imaging and 1H magnetic resonance imaging.
Morikawa S; Inubushi T; Kito K
Cardiovasc Surg; 1993 Aug; 1(4):337-42. PubMed ID: 8076056
[TBL] [Abstract][Full Text] [Related]
12. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
[TBL] [Abstract][Full Text] [Related]
13. Epileptic brain damage: pathophysiology and neurochemical pathology.
Siesjö BK; Wieloch T
Adv Neurol; 1986; 44():813-47. PubMed ID: 2871725
[TBL] [Abstract][Full Text] [Related]
14. Opioid receptor antagonist nalmefene stereospecifically inhibits glutamate release during global cerebral ischemia.
Graham SH; Shimizu H; Newman A; Weinstein P; Faden AI
Brain Res; 1993 Dec; 632(1-2):346-50. PubMed ID: 7908601
[TBL] [Abstract][Full Text] [Related]
15. Chronic administration of ethyl docosahexaenoate reduces gerbil brain eicosanoid productions following ischemia and reperfusion.
Cao D; Zhou C; Sun L; Xue R; Xu J; Liu Z
J Nutr Biochem; 2006 Apr; 17(4):234-41. PubMed ID: 16098734
[TBL] [Abstract][Full Text] [Related]
16. Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine.
Headrick JP
J Mol Cell Cardiol; 1996 Jun; 28(6):1227-40. PubMed ID: 8782064
[TBL] [Abstract][Full Text] [Related]
17. Cerebral metabolite dynamics during temporary complete ischemia in rats monitored by time-shared 1H and 31P NMR spectroscopy.
Chang LH; Shirane R; Weinstein PR; James TL
Magn Reson Med; 1990 Jan; 13(1):6-13. PubMed ID: 2319935
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the neuroprotective effects of the N-methyl-D-aspartate antagonist MK-801 and the opiate-receptor antagonist nalmefene in experimental spinal cord ischemia.
Yum SW; Faden AI
Arch Neurol; 1990 Mar; 47(3):277-81. PubMed ID: 2178593
[TBL] [Abstract][Full Text] [Related]
19. Effect of temperature in focal ischemia of rat brain studied by 31P and 1H spectroscopic imaging.
Kozlowski P; Buchan AM; Tuor UI; Xue D; Huang ZG; Chaundy KE; Saunders JK
Magn Reson Med; 1997 Mar; 37(3):346-54. PubMed ID: 9055223
[TBL] [Abstract][Full Text] [Related]
20. [Studies of experimental cerebral ischemia with NMR spectroscopy].
Hossmann KA
Arzneimittelforschung; 1991 Mar; 41(3A):292-8. PubMed ID: 1859498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
